ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,028Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 559

$698K Total Retail Price of All Prescriptions

Rank: 15 out of 559

676 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 676 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 676 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 9,714 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 695 612 1 2
LISINOPRIL 524 438 2 1
OMEPRAZOLE 376 285 3 4
SIMVASTATIN 374 321 4 3
ATENOLOL 344 313 5 15
AMLODIPINE BESYLATE 340 325 6 6
LOVASTATIN 324 300 7 10
HYDROCHLOROTHIAZIDE 318 276 8 8
METFORMIN HCL 260 209 9 5
GABAPENTIN 230 195 10 9
CITALOPRAM HBR 210 156 11 21
HYDROCODONE-ACETAMINOPHEN 197 156 S3 12 7
ADVAIR DISKUS 171 156 13 46
FUROSEMIDE 162 138 14 11
LOSARTAN POTASSIUM 156 138 15 14
METOPROLOL SUCCINATE 149 140 16 16
GLYBURIDE 146 115 R 17 45
METOPROLOL TARTRATE 133 123 18 12
SERTRALINE HCL 132 91 19 19
RANITIDINE HCL 132 110 19 26
FENOFIBRATE 129 88 21 69
ZOLPIDEM TARTRATE 123 99 22 17
VENLAFAXINE HCL ER 114 105 23 111
PAROXETINE HCL 113 82 24 48
JANUVIA 111 86 25 50
TRAMADOL HCL 109 77 26 27
OXYCODONE-ACETAMINOPHEN 109 59 S2 26 44
FLUTICASONE PROPIONATE 106 80 28 22
FLUOXETINE HCL 100 79 29 37
SPIRONOLACTONE 94 72 30 74
TRAZODONE HCL 89 82 31 28
ATORVASTATIN CALCIUM 86 66 32 20
POTASSIUM CHLORIDE 85 71 33 23
PANTOPRAZOLE SODIUM 83 59 34 41
OXYCODONE HCL 82 32 S2 35 32
AMITRIPTYLINE HCL 80 45 R 36 58
MORPHINE SULFATE ER 79 54 S2 37 63
NAMENDA 79 70 37 56
ESTRADIOL 78 46 R 39 117
CELEBREX 77 64 40 86
PROAIR HFA 75 47 41 29
MIRTAZAPINE 74 74 42 61
OXYBUTYNIN CHLORIDE 73 50 43 62
ALENDRONATE SODIUM 72 69 44 13
MELOXICAM 71 60 45 42
CYMBALTA 70 57 46 78
SPIRIVA 68 61 47 67
FELODIPINE ER 67 67 48 72
BUPROPION HCL SR 65 46 49 114
TRIAMTERENE-HCTZ 62 62 50 47
GEMFIBROZIL 62 51 50 71
SINGULAIR 62 51 50 130
IBUPROFEN 59 45 53 30
TRIAMCINOLONE ACETONIDE 57 43 54 84
DONEPEZIL HCL 57 47 54 36
PROPRANOLOL HCL 57 42 54 119
MORPHINE SULFATE 56 29 S2 57 194
LEVOTHROID 56 52 57 99
DICLOFENAC SODIUM 55 54 59 81
ZETIA 53 35 60 101
CLOPIDOGREL 52 43 61 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.